Data as of 1:43pm ET
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.50 and a low estimate of 2.50. The median estimate represents a +47.06% increase from the last price of 2.04.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.